Session 4: Infectious diseases II: Tuberculosis
2:00 PM – What are the Prospects for Long Acting Therapy for Tuberculosis
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
2:15 PM – Healthcare and Public Health Implications
Michel Gasana, MD, MPH
UZIMA Health Initiatives, Rwanda
2:30 PM – Audience Q&A
